Advertisement

Topics

Stoke Therapeutics Announces $90M Series B Financing to Advance Novel Oligonucleotide Medicines ⁦@StokeTx⁩ https://www.businesswire.com/news/home/20181023005249/en/Stoke-Therapeutics-Announces-90-Million-Series-Financing …

07:10 EDT 23 Oct 2018 | Odi Bruckman

Stoke Therapeutics Announces $90M Series B Financing to Advance Novel Oligonucleotide Medicines ⁦ https://www.businesswire.com/news/home/20181023005249/en/Stoke-Therapeutics-Announces-90-Million-Series-Financing …

Original Article: Stoke Therapeutics Announces $90M Series B Financing to Advance Novel Oligonucleotide Medicines ⁦@StokeTx⁩ https://www.businesswire.com/news/home/20181023005249/en/Stoke-Therapeutics-Announces-90-Million-Series-Financing …

NEXT ARTICLE

More From BioPortfolio on "Stoke Therapeutics Announces $90M Series B Financing to Advance Novel Oligonucleotide Medicines ⁦@StokeTx⁩ https://www.businesswire.com/news/home/20181023005249/en/Stoke-Therapeutics-Announces-90-Million-Series-Financing …"

Advertisement
Quick Search
Advertisement
Advertisement